Поисковый запрос: (<.>S=ФАРМАКОГЕНОМИКА<.>) |
Общее количество найденных документов : 71
Показаны документы с 1 по 20
|
|
1.
| Pickar D. The industrialization of pharmacogenomics for psychiatric disorders // Amer. J. Med. Genet., 2000. Vol. 96, N 4.-С.467
|
2.
| Diasio R.B. The role of pharmacogenetics and pharmacogenmics in cancer chemotherapy with 5-fluorouracil // Pharmacology, 2000. Vol. 61, N 3.-С.199-203
|
3.
| Hua Успехи в исследованиях по фармакогеномике // Yaoxue xuebao, 2002. Vol. 37, N 8.-С.668-672
|
4.
| Recent progress in 'альфа'[1]-adrenoceptor pharmacology // Biol. and Pharm. Bull., 2002. Vol. 25, N 4.-С.401-408
|
5.
| Pirmohamed Pharmacogenetics and pharmacogenomics // Brit. J. Clin. Pharmacol., 2001. Vol. 52, N 4.-С.345-347
|
6.
| Pirmohamed Pharmacogenetics and pharmacogenomics // Brit. J. Clin. Pharmacol., 2001. Vol. 52, N 4.-С.345-347
|
7.
| Kalow Pharmacogenetics,pharmacogenomics, and pharmacobiology // Clin. Pharmacol. and Ther., 2001. Vol. 70, N 1.-С.1-4
|
8.
| CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans // Clin. Pharmacol. and Ther., 1999. Vol. 65, N 5.-С.552-561
|
9.
| Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein // Clin. Pharmacol. and Ther., 2002. Vol. 72, N 2.-С.209-219
|
10.
| Kawanishi Pharmacogenomics and schizophrenia // Eur. J. Pharmacol., 2000. Vol. 410, N 2-3.-С.227-241
|
11.
| Li Достижения исследований по фармакогеномике и обоснованное использование лекарственных средств // Shenyang yaoke daxue xuebao, 2004. Vol. 21, N 1.-С.70-75
|
12.
| Lee C.R. CYP2C9 genotype as a predictor of drug disposition in humans // Meth. and Find. Exp. and Clin. Pharmacol., 2004. Vol. 26, N 6.-С.463-472
|
13.
| Phillips Kathryn A. Cost-effectiveness issues in pharmacogenomics // Drug Metab. Rev., 2002. Vol. 35, прил. 1.-С.20
|
14.
| Evans William E. Pharmacogenomics of childhood acute leukemia // Drug Metab. Rev., 2002. Vol. 35, прил. 1.-С.11
|
15.
| McLeod Howard L. Cancer pharmacogenomics: SNPs, chips, and the individual patient // Cancer Invest., 2003. Vol. 21, N 4.-С.630-640
|
16.
| McLeod Howard L. Cancer pharmacogenomics: SNPs, chips, and the individual patient // Cancer Invest., 2003. Vol. 21, N 4.-С.630-640
|
17.
| Drug development in oncology: Classical cytotoxics and molecularly targeted agents // Brit. J. Clin. Pharmacol., 2006. Vol. 61, N 1.-С.15-26
|
18.
| Drug development in oncology: Classical cytotoxics and molecularly targeted agents // Brit. J. Clin. Pharmacol., 2006. Vol. 61, N 1.-С.15-26
|
19.
| Innocentic "Irinogenetics" and UGT1A: From genotypes to haplotypes // Clin. Pharmacol. and Ther., 2004. Vol. 75, N 6.-С.495-500
|
20.
| Cheok Meyling H. Pharmacogenomics of acute leukemia // Annual Review of Pharmacology and Toxicology. -Palo Alto (Calif.), 2006. 2006, Vol. 46.-С.317-353
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"